Related Experiment Videos
Hypercalcaemia secondary to hepatocellular carcinoma
N Leone1, W Debernardi-Venon, A Marzano
1Department of Gastroenterology, Molinette Hospital, Turin, Italy.
Italian Journal of Gastroenterology and Hepatology
|December 22, 1999
Summary
This study reports a rare case of coma due to persistent hypercalcemia in a cirrhotic patient. The patient was not previously diagnosed with hepatocellular carcinoma, highlighting a rare metabolic complication of cancer.
Area of Science:
- Endocrinology
- Oncology
- Hepatology
Background:
- Metabolic syndromes are often linked to neoplastic diseases.
- Pseudohyperparathyroidism, or hypercalcemia secondary to malignancy without bone metastases, can mimic primary hyperparathyroidism.
- Differentiating pseudohyperparathyroidism from primary hyperparathyroidism is challenging and necessitates ruling out occult malignancy.
Observation:
- Hypercalcemia is a known complication of hepatocellular carcinoma.
- This report details an unusual case of coma with persistent hypercalcemia in a cirrhotic patient.
- The patient had no prior diagnosis of hepatocellular carcinoma.
Findings:
- The patient presented with coma and persistent hypercalcemia.
- Hepatocellular carcinoma was identified as the underlying cause in this cirrhotic patient.
- This case illustrates a rare presentation of malignancy-associated hypercalcemia.
Implications:
- Early detection of occult malignancy is crucial, especially before parathyroid surgery.
- This case underscores the importance of considering malignancy-induced hypercalcemia in patients with liver cirrhosis.
- Further research into the mechanisms and management of rare metabolic complications in cancer patients is warranted.